Pay in 4 interest-free payments of $6.49 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
In two phase 3 clinical trials, retatrutide, a novel glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP-1), and glucagon triple-hormone receptor agonist, demonstrated significant weight loss and clinically meaningful improvements in health outcomes in people living with obesity and type 2 diabetes
This insight informs dietary choices aimed at reducing inflammation and promoting neural recovery
The tablet doses are not equivalent to the same milligram amounts given by injection
100% Transparent Label
For a subcutaneous (SubQ) injection, a finer, shorter needle is used, around 25 to 27 gauge and half to five-eighths of an inch
US$ 23.71
US$ 27.09
US$ 28.52
US$ 22.39
